康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00867 康哲药业

未开盘 05-02 16:08:16

7.380

+0.370

+5.28%

最高7.380	最低6.890	成交量804.99万
今开7.010	昨收7.010	日振幅6.99%
总市值180.96亿	流通市值180.96亿	总股本24.52亿
成交额5,789万	换手率0.33%	流通股本24.52亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00867","market":"HK","secType":"STK","nameCN":"康哲药业","latestPrice":7.38,"timestamp":1714637296024,"preClose":7.01,"halted":0,"volume":8049913,"delay":0,"floatShares":2451988512,"shares":2451988512,"eps":1.0620586,"marketStatus":"未开盘","marketStatusCode":0,"change":0.37,"latestTime":"05-02 16:08:16","open":7.01,"high":7.38,"low":6.89,"amount":57886863,"amplitude":0.0699,"askPrice":7.39,"askSize":31000,"bidPrice":7.38,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":1.0620585272056757,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714699800000},"adr":0,"adjPreClose":7.01,"dividendRate":0.057587,"openAndCloseTimeList":[[1714613400000,1714622400000],[1714626000000,1714636800000]],"volumeRatio":0.9520662461566837,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00867/","defaultTab":"news","newsList":[{"id":"2432380644","title":"康哲药业(00867)上涨5.14%，报7.37元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432380644","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432380644?lang=zh_cn&edition=full","pubTime":"2024-05-02 15:12","pubTimestamp":1714633968,"startTime":"0","endTime":"0","summary":"5月2日，康哲药业(00867)盘中上涨5.14%，截至15:12，报7.37元/股，成交4347.64万元。康哲药业控股有限公司主要业务是与全球生物科技和制药公司合作，开发全球首创和同类最优的创新产品，专注于心脑血管、消化、中枢神经、皮肤/医美、眼科、儿科等专科疾病领域。公司在过去十五年(2008-2022)的销售额和净利润的年度复合增长率均超过20%，并通过专科线分拆独立运营，整合专科疾病领域优势资源，推动集团高质量、可持续的健康发展。截至2023年年报，康哲药业营业总收入80.13亿元、净利润24.01亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02151240509924.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2432643125","title":"医美概念股走高 四环医药(00460)涨8.77% 国金证券指医美行业仍处于高景气发展阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2432643125","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2432643125?lang=zh_cn&edition=full","pubTime":"2024-05-02 14:06","pubTimestamp":1714630013,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医美概念股走高，四环医药(00460)涨8.77%，复锐医疗科技(01696)涨8.15%，三生制药(01530)涨5.41%，医思健康(02138)涨5.34%，康哲药业(00867)涨4.56%，复星医药(02196)涨2.76%。国金证券表示，看好兼具技术、产品、品牌储备的国内医美龙头。现阶段受到情绪面的影响，国内医美板块估值已经回调至相对低位。展望国内医美行业未来发展，该行认为行业仍处于高景气发展阶段。未来我国医美行业发展有望受益于合规产品占比提升与医美渗透率提升的双重驱动，竞争格局不断优化，新需求持续放量，行业业绩和估值有较大提升空间。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1936162","is_publish_highlight":false,"gpt_icon":0},{"id":"2429451440","title":"康哲药业(00867.HK)4月24日回购105.00万股 耗资738.72万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429451440","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2429451440?lang=zh_cn&edition=full","pubTime":"2024-04-24 21:51","pubTimestamp":1713966707,"startTime":"0","endTime":"0","summary":"证券时报·数据宝统计，康哲药业在港交所公告显示，4月24日以每股7.010港元至7.050港元的价格回购105.00万股，回购金额达738.72万港元。该股当日收盘价7.030港元，下跌0.99%，全天成交额5708.03万港元。今年以来该股累计进行10次回购，合计回购1246.00万股，累计回购金额9161.36万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404243057938020.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404243057938020.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429431393","title":"康哲药业(00867)4月24日斥资738.72万港元回购105万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429431393","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2429431393?lang=zh_cn&edition=full","pubTime":"2024-04-24 18:51","pubTimestamp":1713955904,"startTime":"0","endTime":"0","summary":"康哲药业(00867)发布公告，于2024年4月24日斥资738.72万港元回购股...","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_36.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_36.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108810.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429211341","title":"智通港股早知道 | 一季度国内动力电池装机量同比增长43% iPhone在华销量锐减19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429211341","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429211341?lang=zh_cn&edition=full","pubTime":"2024-04-24 07:32","pubTimestamp":1713915121,"startTime":"0","endTime":"0","summary":"GGII：第一季度国内动力电池装机量约84.3GWh 同比增长43%智通财经APP获悉，在新车上市、降价促销以及以旧换新政策刺激下，2024年第一季度国内新能源汽车延续快速增长势态。其中，第一季度新能源汽车销量前十企业合计装机约56.8GWh，占整个动力电池装机量的67.4%，宁德时代和比亚迪动力电池分别配套销量前十企业49%和37%的份额。2024年第一季度，特斯拉的汽车收入同比下降13%，至173.4亿美元。备案通知书将自2024年4月18日起12个月内有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108158.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429026117","title":"康哲药业(00867.HK)德昔度司他片上市许可申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2429026117","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429026117?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:48","pubTimestamp":1713890880,"startTime":"0","endTime":"0","summary":"康哲药业(00867.HK) 公布，德昔度司他片(原名：德度司他片)新药上市许可申请已获中国国家药品监督管理局受理。该产品为一种创新型口服低氧诱导因子-脯氨酰羟化酶抑制剂，拟用于非透析的成人慢性肾脏病患者的贫血治疗。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-23 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20190604131519775_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344430/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429196453","title":"康哲药业(00867)：德昔度司他片中国上市许可申请已获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2429196453","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429196453?lang=zh_cn&edition=full","pubTime":"2024-04-23 20:08","pubTimestamp":1713874091,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，德昔度司他片新药上市许可申请已于2024年4月22日获得中国国家药品监督管理局受理。CKD患者肾功能逐渐丧失，最终出现肾衰竭。如果肾功能受损，肾脏生成EPO水平下降或完全不生成EPO，从而导致贫血。产品采用口服给药，有望提高患者的治疗顺应性，有望满足CKD贫血领域未被满足的治疗需求。产品已在印度获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1107879.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429150674","title":"康哲药业04月23日获主力加仓784万元 环比增加892.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429150674","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429150674?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:15","pubTimestamp":1713860111,"startTime":"0","endTime":"0","summary":"04月23日, 康哲药业股价跌1.25%，报收7.10元，成交金额5692万元，换手率0.33%，振幅4.03%，量比0.67。康哲药业今日主力资金净流入784万元，上一交易日主力净流入79万元，今日环比增加892.41%。该股近5个交易日下跌1.26%，主力资金累计净流入4429万元；近20日主力资金累计净流入5692万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231615268b49b025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404231615268b49b025&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428350238","title":"康哲药业(00867)出现大手成交330万股，成交价$6.935，涉资2.289千万","url":"https://stock-news.laohu8.com/highlight/detail?id=2428350238","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428350238?lang=zh_cn&edition=full","pubTime":"2024-04-19 13:00","pubTimestamp":1713502800,"startTime":"0","endTime":"0","summary":"[大手成交]康哲药业(00867)在下午01:00出现大手成交，成交量为330万，成交价为港币$6.935，涉资2.289千万。至目前为止，股价跌1.7%，今日最高价为$7.05，而最低价为$6.85，总成交量为663.908万股，总成交金额港币$4.604千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126132514810_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2404193057/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428591651","title":"康哲药业2023年营收净利双降12.4%和27.2%：面对国采政策影响的创新药布局与市场拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2428591651","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428591651?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:01","pubTimestamp":1713445284,"startTime":"0","endTime":"0","summary":"\\u003cp\\u003e\\u003cbr\\u003e 康哲药业2023年年报显示，公司实现营收80.13亿元，同比下降12.4%；年度溢利23.84亿元，同比下降27.2%。这是公司自2010年上市以来首次出现营收和净利润双降。\\u003cbr\\u003e 康哲药业表示，集采影响将在2023年下半年和2024年上半年逐步消退，公司将依靠独家和创新药为主的产品结构，回归健康增长轨道。二级市场上，公司股价在2023年业绩公告后暴跌34.45%，之后持续疲软。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182133358b363af8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182133358b363af8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428550936","title":"主力产品失速，营收、净利双双下滑，康哲药业如何重回正轨？","url":"https://stock-news.laohu8.com/highlight/detail?id=2428550936","media":"时代周报","top":-1,"share":"https://www.laohu8.com/m/news/2428550936?lang=zh_cn&edition=full","pubTime":"2024-04-18 17:19","pubTimestamp":1713431946,"startTime":"0","endTime":"0","summary":"根据历年财报数据，这是2010年上市后，康哲药业首次出现营收、净利润双双下滑。届时，公司品种结构将以独家和创新药为主，更为健康的产品结构将支撑康哲药业重回持续健康增长轨道的起点。国采冲击主力业务受国采影响的三款产品分别为黛力新、波依定和优思弗，均是康哲药业在不同时期获得销售权益的代理产品。从各板块营收情况来看，心脑血管线和消化线占据康哲药业的营收大头。康哲药业方面表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719318b35403b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181719318b35403b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428816303","title":"康哲药业耗资742.38万港元回购106万股 股票回购增资行业分析","url":"https://stock-news.laohu8.com/highlight/detail?id=2428816303","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428816303?lang=zh_cn&edition=full","pubTime":"2024-04-18 04:00","pubTimestamp":1713384045,"startTime":"0","endTime":"0","summary":"据康哲药业公告，该公司于2023年4月17日，通过港交所交易系统以总成交金额742.38万港元购回106万股股份，每股平均购回价格约为7.01港元。值得注意的是，康哲药业在2022年取得了较好的业绩，公司全年实现营业收入19.23亿元，同比增长8.3%；净利润达到9.49亿元，同比增长37.2%，增速远超行业平均。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070202878c0029&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418070202878c0029&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428311937","title":"康哲药业(00867)4月17日斥资742.38万港元回购106万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2428311937","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428311937?lang=zh_cn&edition=full","pubTime":"2024-04-17 19:34","pubTimestamp":1713353663,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，该公司于2024年4月17日斥资742.38万港元回购106万股，回购价为每股6.95港元-7.04港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104064.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428239371","title":"康哲药业04月17日主力资金流入904万元 连续7日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2428239371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428239371?lang=zh_cn&edition=full","pubTime":"2024-04-17 16:15","pubTimestamp":1713341710,"startTime":"0","endTime":"0","summary":"04月17日, 康哲药业股价跌1.12%，报收7.05元，成交金额9975万元，换手率0.58%，振幅6.17%，量比1.13。康哲药业今日主力资金净流入904万元，连续7日净流入，上一交易日主力净流入1155万元，今日环比减少21.73%。该股近5个交易日下跌4.19%，主力资金累计净流入3882万元；近20日主力资金累计净流入1281万元，其中净流入天数为11日。该股主力净额占比0.05%，港股市场排名85/2627。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615208787fb44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171615208787fb44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427787651","title":"康哲药业(00867)：磷酸芦可替尼乳膏中国澳门新药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2427787651","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427787651?lang=zh_cn&edition=full","pubTime":"2024-04-16 22:43","pubTimestamp":1713278581,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业 发布公告，该公司欣然宣布，中华人民共和国澳门特别行政区政府药物监督管理局已于2024年4月11日批准磷酸芦可替尼乳膏(产品)新药上市申请，于2024年4月16日收到药品注册证书。产品用于治疗12岁及以上青少年和成人患者伴面部受累的非节段型白癜风。Incyte拥有磷酸芦可替尼乳膏全球开发和商业化权利，在美国及欧洲以Opzelura的名称销售。集团正有序推进芦可替尼乳膏在中国澳门的商业化工作，早日造福白癜风患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103612.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427676074","title":"康哲药业(00867)4月15日斥资744.4万港元回购105万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427676074","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427676074?lang=zh_cn&edition=full","pubTime":"2024-04-15 19:58","pubTimestamp":1713182280,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康哲药业(00867)发布公告，于2024年4月15日该公司斥资744.4万港元回购105万股股份，每股回购价格为7.04-7.16港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1102785.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2427099032","title":"康哲药业(00867.HK)回购105万股 涉资约764.27万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427099032","media":"财华社","top":-1,"share":"https://www.laohu8.com/m/news/2427099032?lang=zh_cn&edition=full","pubTime":"2024-04-15 09:25","pubTimestamp":1713144357,"startTime":"0","endTime":"0","summary":"【财华社讯】康哲药业(00867.HK)公布，于2024年04月12日回购105万股，每股回购价介乎7.21港元至7.35港元，涉资约764.27万港元。","market":"hk","thumbnail":"https://www.finet.hk/images/news_default.jpg","type":0,"news_type":0,"thumbnails":["https://www.finet.hk/images/news_default.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/661c8226643dcf84e4ccd3fe","is_publish_highlight":false,"gpt_icon":0},{"id":"2426462210","title":"康哲药业4月11日斥资799.3万港元回购110万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426462210","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2426462210?lang=zh_cn&edition=full","pubTime":"2024-04-12 08:11","pubTimestamp":1712880682,"startTime":"0","endTime":"0","summary":"康哲药业（00867）发布公告，于2024年4月11日该公司斥资799.3万港元回购110万股，回购价格为每股7.16-7.34港元。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzf0609173.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-04-12/doc-inarpmzf0609173.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cms.net.cn","stockEarnings":[{"period":"1week","weight":0.0438},{"period":"1month","weight":-0.0225},{"period":"3month","weight":-0.3446},{"period":"6month","weight":-0.4366},{"period":"1year","weight":-0.4011},{"period":"ytd","weight":-0.4668}],"compareEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0753},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0307},{"period":"1year","weight":-0.0757},{"period":"ytd","weight":0.068}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"康哲药业控股有限公司是一家主要从事医药产品的制造、推广、营销及销售业务的香港投资控股公司。其直接网络主要产品包括黛力新、优思弗、新活素、莎尔福、亿活及施图伦滴眼液等。其代理商推广网络产品包括沙多力卡、伊诺舒及喜达康等。其产品用于治疗胃病、心脏病、外伤感染、肝病及眼疾等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.011253},{"month":2,"riseRate":0.538462,"avgChangeRate":0.023854},{"month":3,"riseRate":0.5,"avgChangeRate":0.004125},{"month":4,"riseRate":0.5,"avgChangeRate":0.022227},{"month":5,"riseRate":0.5,"avgChangeRate":-0.001463},{"month":6,"riseRate":0.615385,"avgChangeRate":-0.002502},{"month":7,"riseRate":0.538462,"avgChangeRate":-0.016997},{"month":8,"riseRate":0.384615,"avgChangeRate":0.016149},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.018576},{"month":10,"riseRate":0.571429,"avgChangeRate":0.02168},{"month":11,"riseRate":0.571429,"avgChangeRate":0.06235},{"month":12,"riseRate":0.642857,"avgChangeRate":0.044014}],"exchange":"SEHK","name":"康哲药业","nameEN":"CMS"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康哲药业,00867,康哲药业股票,康哲药业股票老虎,康哲药业股票老虎国际,康哲药业行情,康哲药业股票行情,康哲药业股价,康哲药业股市,康哲药业股票价格,康哲药业股票交易,康哲药业股票购买,康哲药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康哲药业(00867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康哲药业(00867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}